FDA Inspection 1247299 — Celltrion Pharm, Inc.
The FDA completed an inspection of Celltrion Pharm, Inc. on July 23, 2024 in Cheongju. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 23, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cheongju (Korea (the Republic of))